Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)’s interesting series of developments are underway around the US stock market these days. Now trading with a market value of 101.21M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Fundamentals That Matter
It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health […]
Full Post at eglobalist.com